| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |